Target intelligence / Profile preview

STIL centriolar assembly protein (STIL)

Target
STIL
Molecular classification
Other (centrosomal/centriolar assembly protein), Scaffold/structural protein, Immediate-early gene
01

Overview

STIL centriolar assembly protein (STIL) is a cytoplasmic protein crucial for centriole replication and for de novo centriole biogenesis, which is essential during mammalian embryogenesis[1]. It regulates the mitotic spindle checkpoint to monitor chromosome segregation, ensuring proper distribution of chromosomes during cell division, and is required for activating the spindle checkpoint through its interaction with mitotic regulators. STIL has fundamental roles in cell cycle progression, cell proliferation, and embryonic development. Loss-of-function mutations in STIL are linked to autosomal recessive primary microcephaly (MCPH7), and chromosomal deletions involving STIL are seen in some forms of T-cell leukemia[2][3]. At a molecular level, STIL interacts with other centriolar proteins such as CPAP and PLK4, participating in the assembly and duplication of centrioles via its coiled-coil domain[1][3]. No approved drugs directly target STIL, but its genetic alterations function as disease biomarkers in some contexts[2][3].

Other names
SCL-interrupting locus proteinSILMCPH7TAL-1-interrupting locus proteinSCL/TAL1 interrupting locusSTIL_HUMANSCL-interrupting locusSTIL
02

Mechanism of action

Not applicable for drugs, as no direct pharmacological modulators are known.

03

Biological functions

Centriole duplicationMitotic spindle checkpoint regulationChromosome segregationEmbryonic developmentCellular growth and proliferation
04

Disease associations

Primary microcephaly (MCPH7)Precursor T-cell acute lymphoblastic leukemiaOther genetic syndromes affecting neurodevelopment
05

Safety considerations

No specific safety concerns, as it is not a direct therapeutic target; nevertheless, genetic disruptions can lead to severe developmental disorders
06

Biomarkers

STIL gene mutations (biomarker for primary microcephaly subtype MCPH7)STIL fusion events (such as those with adjacent loci in leukemias) may serve as diagnostic biomarkers

Beyond the preview

Go deeper on STIL centriolar assembly protein (STIL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on STIL centriolar assembly protein (STIL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call